diet physical*sustained weight loss*interventionist*weight weekly*medical monitoring*weight maintenance program*medical care setting*diet choice*ongoing monitoring*comprehensive weight maintenance*group session*total meal replacement*baseline body weight*lifestyle intervention*maintenance counseling*weight maintenance counseling*loss such program*comprehensive weight*meal replacement*comprehensive weight loss*lifestyle program*weight maintenance*monthly contact*such program*weight loss maintenance*energy deficit*loss goal*behavioral therapy*loss sustained weight*term weight loss*necessary energy*diet physical activity*intensive behavioral lifestyle*loss maintenance program*such intervention*term weight*behavioral lifestyle*body weight weekly*necessary energy deficit*sustained weight*least monthly contact*total meal*trained practitioner*loss maintenance*obese patient*maintenance program*care setting*baseline body*trained interventionists*behavioral strategy*close medical monitoring*behavioral lifestyle intervention*trained interventionist*calorie diet*interventionists*weight loss goal*short term weight
weight loss treatment*weight management program*medical monitoring*severe obesity*retrospective analysis*medical therapy*cohort study*comprehensive weight*lifestyle support*body mass index*bariatric*gastric banding*effective weight*metabolic profile*optimal medical therapy*bmi*loss treatment*effective weight loss*nonsurgical*bariatric surgery*such study*obese patient*modeling study*longer study*stomach stapling*pharmacological therapy*lifelong lifestyle*comprehensive weight management*pharmacological*metabolic surgery*nonsurgical subject*lifelong lifestyle support*such patient
aglucosidase*diet physical*metformin hydrochloride*insufficient weight loss*adjunct*lowering medication*diabetes provider*treatment approach*weight loss medication*body mass index*behavioral counseling*glucose lowering medication*glucose lowering*reproductive year*tolerability*glucophage*successful weight*alternative medication*possible medication*tolerability issue*loss medication*concomitant medication*combination therapy*bmi*diet physical activity*product label*aglucosidase inhibitor*insufficient weight*metformin*obese patient*successful weight loss*reliable method*pharmacological treatment*alpha glucosidase*pharmacological
metformin hydrochloride*activity goal*rate gfr*filtration rate*glycemic goal*glomerular filtration rate*glomerular filtration*longstanding evidence base*min week*physical activity goal*goal metformin monotherapy*glucophage*ml min*lower gfr range*counseling setting*filtration rate gfr*week minimum*goal metformin*cardiovascular event*metformin monotherapy*glomerular*metformin*gfr*longstanding evidence*min week minimum*lower gfr*glycemic*lifestyle effort*observational data*glycemic goal metformin*gfr range
loss ketosis*ongoing glycemia reduction*inhibitor glp1 analog*glycemic effect*inhibitor glp1*sulfonylurea dpp4*dpp4*economic outcome*dpp4 inhibitor glp1*specific situation*comparative effectiveness study*moderate glycemic effect*dipeptidyl peptidase*glucose toxicity*comparative effectiveness*catabolic feature weight*postprandial hypoglycemia*study grade*reduction approach*glycemia*glp1 analog*dpp4 inhibitor*postprandial*fasting hypoglycemia*dpp iv*secretagogues meglitinides*newer agent*feature weight loss*sulfonylurea*secretagogues*late postprandial hypoglycemia*class sulfonylurea dpp4*effectiveness study grade*health economic outcome*weight loss ketosis*irregular meal*basal insulin*ongoing glycemia*class sulfonylurea*analog*glp 1*major drug*feature weight*moderate glycemic*catabolic feature*glucagon like peptide*effectiveness study*meglitinides*glycemia reduction*irregular meal schedule*medical psychosocial*meal schedule*drug class*hypoglycemia*glp1*drug class sulfonylurea*glycemia reduction approach*major drug class*glycemic*combination regimen*dpp 4*sulfonylurea dpp4 inhibitor*glycemic control
hba1c*glargine*sulfonylurea dpp4*adjunctive*insulin dosing*dpp4 inhibitor glp1*pioglitazone*postprandial hypoglycemia*pharmacodynamic profile*dpp4 inhibitor*glp1 receptor agonist*dpp iv*sulfonylurea*progressive nature*serial lung function*complex insulin regimen*postprandial glucose excursion*suboptimal blood glucose*postprandial glucose*suboptimal blood*glucagon like peptide*nph*complex insulin*glucose excursion*hypoglycemia*basal insulin analog*bolus insulin dosing*lispro*lung function testing*pharmacodynamic*sulfonylurea dpp4 inhibitor*insulin analog*dosing range*initiate insulin therapy*glucose control*limited dosing range*better absorption*injectable therapy*csii*initiate insulin*combination injectable therapy*noninsulin*insulin dos*hemoglobin a1c*insulin regimen*accurate dosing*analog*blood glucose control*prandial*u300*thiazolidinediones*dos adjunctive use*sodium glucose cotransporter*goal provider*smaller volume*insulin administration*longer duration*dpp4*inhibitor glp1*glycemic goal*bolus insulin*glycemic goal provider*suboptimal*insulin analog people*u300 glargine*basal insulin*sglt2*degludec*regimen flexibility*adjunctive use*sglt2 inhibitor*limited dosing*prandial use*glp1*serial lung*u200 degludec*dpp 4*a1c*noninsulin agent*concentrated preparation*dipeptidyl peptidase*glp1 receptor*fasting hypoglycemia*postprandial*sglt 2*u200*part mix*blood glucose level*glp 1*acceptable fasting blood*insulin therapy*receptor agonist*biphasic*glucose level*analog people*glycemic*acceptable fasting
min week*metformin
